dc.contributor.author | KAPAN, Selin | |
dc.contributor.author | Dagoglu, Nergiz | |
dc.contributor.author | Tambas, Makbule | |
dc.contributor.author | Karabulut, Senem | |
dc.contributor.author | Oguz, Hilal | |
dc.contributor.author | ORAN, Ebru | |
dc.contributor.author | KARABULUT, Mehmet | |
dc.contributor.author | ALIS, Halil | |
dc.contributor.author | Tas, Faruk | |
dc.date.accessioned | 2021-03-05T21:34:59Z | |
dc.date.available | 2021-03-05T21:34:59Z | |
dc.date.issued | 2016 | |
dc.identifier.citation | Karabulut S., KARABULUT M., ALIS H., Dagoglu N., Tambas M., KAPAN S., ORAN E., Oguz H., Tas F., "The predictive and prognostic value evaluation of serum extracellular matrix proteins levels in patients with pancreas adenocarcinoma", MEDICAL JOURNAL OF BAKIRKOY, cilt.12, ss.24-32, 2016 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_d993aab7-570b-4523-a347-f4eb514a4eed | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/143484 | |
dc.identifier.uri | https://doi.org/10.5350/btdmjb201612105 | |
dc.description.abstract | Objective: Fibronectin (FN), vitronectin (VTN), and tip IV kollagen (Kol IV) are the important components of the extracellular matrix (ECM) proteins. The objective of this study was to determine the clinical significance of serum levels of these molecules in pancreas adenocarcinoma (PA) patients. | |
dc.language.iso | eng | |
dc.subject | Tıp | |
dc.subject | TIP, GENEL & İÇECEK | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Temel Tıp Bilimleri | |
dc.subject | Sağlık Bilimleri | |
dc.title | The predictive and prognostic value evaluation of serum extracellular matrix proteins levels in patients with pancreas adenocarcinoma | |
dc.type | Makale | |
dc.relation.journal | MEDICAL JOURNAL OF BAKIRKOY | |
dc.contributor.department | Bakirkoy Dr. Sadi Konuk Research & Training Hospital , , | |
dc.identifier.volume | 12 | |
dc.identifier.issue | 1 | |
dc.identifier.startpage | 24 | |
dc.identifier.endpage | 32 | |
dc.contributor.firstauthorID | 38175 | |